COMMUNIQUÉS West-GlobeNewswire

Onconova Therapeutics, Inc. Reports Business Highlights and Third Quarter 2017 Financial Results

09/11/2017 - 13:00

NEWTOWN, Pa., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX ), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat [...]

TearLab Corporation Begins Trading on OTCQB

09/11/2017 - 13:00

SAN DIEGO, Nov. 09, 2017 (GLOBE NEWSWIRE) -- TearLab Corporation (OTCQB:TEAR) (TSX: TLB ) (“TearLab” or the “Company”), today announced that shares of its common stock will begin trading on the OTCQB Market, which is [...]

Recro Pharma Reports Third Quarter 2017 Financial Results

09/11/2017 - 13:00

NDA Submission for IV Meloxicam Accepted by U.S. FDA for Review; PDUFA Date Set for May 26, 2018 Strong Gainesville Manufacturing Performance; Third Quarter 2017 Revenues of $17.1 Million MALVERN, Pa., Nov. 09, 2017 ( [...]

RedHill Biopharma Announces Last Patient Enrolled in the Phase III Study with RHB-104 for Crohn’s Disease

09/11/2017 - 13:00

Top-line results are expected to be announced in mid-2018 The Phase III study evaluating RHB-104 for Crohn’s disease (MAP US study) is a randomized, double-blind, placebo-controlled study that is evaluating the safety [...]

Summit Highlights Utrophin Modulation as a Potential Universal Treatment Option in DMD at 15th Action Duchenne International Conference

09/11/2017 - 13:00

New Preclinical Data Show Utrophin’s Positive Effect on Mitochondria Improving Muscle Health in DMD Model OXFORD, United Kingdom, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ: SMMT ) (AIM:SUMM) the [...]

Alcobra Announces Third Quarter 2017 Financial Results and Provides Corporate Update

09/11/2017 - 13:00

TEL AVIV, Israel, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Alcobra Ltd. (NasdaqGM:ADHD) today announced financial results for the three and nine months ended September 30, 2017, and provided a corporate update. Third Quarter [...]

ProQR Appoints Thaddeus Dryja, M.D. to Scientific Advisory Board

09/11/2017 - 13:00

Key Updates Dr. Thaddeus (Ted) Dryja, a pioneer in the field of retinal genetic diseases, joins the Company’s Scientific Advisory Board. Dr. Dryja will play a key strategic role in the development and advancement of [...]

Purepoint Uranium Acquires Additional Claims, Tripling the Size of McArthur East Project

09/11/2017 - 12:45

TORONTO, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Purepoint Uranium Group Inc. (the “ Company ” or “ Purepoint ”) (TSX-V: PTU ) today reported the staking of 6 new claims adjacent to their 100% owned McArthur East project, [...]

Histogenics Corporation Announces Third Quarter 2017 Financial and Operating Results

09/11/2017 - 12:30

Top-line, 1-year Superiority Data for NeoCart ® Phase 3 Clinical Trial and Potential Biologics License Application Filing Remain on Track for Third Quarter of 2018 Company to Host Conference Call and Webcast Thursday, [...]

Epizyme to Present at the Jefferies 2017 London Healthcare Conference

09/11/2017 - 12:30

CAMBRIDGE, Mass., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Epizyme, Inc. (NASDAQ: EPZM ), a clinical-stage biopharmaceutical company creating novel epigenetic therapies, today announced that management will present a company [...]

INC Research/inVentiv Health Reports Third Quarter 2017 Results

09/11/2017 - 12:20

Highlights Net service revenue of $592.2 million and $1,102.4 million for the three and nine months ended September 30, 2017, respectively. Combined Company adjusted net service revenue of $766.6 million and $2,331.6 [...]

Quotient Limited to Participate in the Jefferies 2017 London Healthcare Conference

09/11/2017 - 12:00

JERSEY, Channel Islands, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT ), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive Officer, Paul Cowan, [...]

iSalus Healthcare Opens New Office in Downtown Indianapolis

09/11/2017 - 12:00

INDIANAPOLIS, Nov. 09, 2017 (GLOBE NEWSWIRE) -- iSalus Healthcare, a premier healthcare technology and services company in Indiana, has recently moved offices to 1 Virginia Avenue, Suite 500, Indianapolis, IN 46204 . [...]

Helius Medical Technologies Announces Positive Results from its Registrational Clinical Trial for Traumatic Brain Injury (TBI)

09/11/2017 - 12:00

NEWTOWN, Pa., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (TSX: HSM ) (OTCQB:HSDT) ("Helius" or the "Company"), a medical technology company focused on neurological wellness, announced results [...]

RadNet Reports Third Quarter Financial Results and Reaffirms Previously Announced 2017 Guidance Levels

09/11/2017 - 12:00

Total Net Revenue (“Revenue”) increased 1.3% to $227.6 million in the third quarter of 2017 from $224.6 million in the third quarter of 2016: Adjusting for the sale of the Rhode Island facilities, Revenue increased 1.9 [...]

Crown Bioscience Inc. Announcing the 2017 Board of Directors Election Results

09/11/2017 - 11:21

TAIPEI, Taiwan, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development services company providing [...]

Ossur Hf : Management Changes

09/11/2017 - 11:01

Announcement Össur hf. No. 81/2017 Reykjavik, 9 November 2017 New R&D leadership Dr. Thorvaldur Ingvarsson, EVP of Research & Development (R&D), has decided to leave Össur after leading the R&D function [...]

Share Capital and Votes

09/11/2017 - 09:21

Pursuant to section 10 of executive order no. 1526 of December 9, 2016 on Issuers' Disclosure Obligations, it is hereby announced, that BioPorto A/S total share capital amounts to DKK 155.509.681 divided into shares of [...]

Bavarian Nordic Announces Initiation of Phase 2 Booster Study of its Universal RSV Vaccine

09/11/2017 - 07:32

Study to help determine if MVA-BN RSV will be administered as a seasonal vaccine or if a single shot is effective for multiple seasons COPENHAGEN, Denmark, November 9, 2017 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) [...]